首页>
外国专利>
USE OF VALSARTAN OR ITS METABOLITE TO IN HIBIT PLATELET AGGREGATION
USE OF VALSARTAN OR ITS METABOLITE TO IN HIBIT PLATELET AGGREGATION
展开▼
机译:缬沙坦或其代谢物在血小板聚集中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to a method of inhibiting platelet aggregation comprising administering a therapeutically effective amount of an ARB or its metabolite, especially Valsartan or its metabolite valeryl 4-hydroxy valsartan. Conditions to be treated by inhibition of platelet aggregation include acute myocardial infarction, ischemic stroke, angina pectoris, acute coronary syndromes, TIA (transient ischemic attacks, or acute cerebrovascular syndromes), heart failure, chest pain of ischemic etiology, syndrome X, thromboembolism, pulmonary hypertension, diabetes mellitus, peripheral vascular disease, deep vein thrombosis, arterial thrombosis of any vessel, catheter thrombotic occlusion or reocclusion.
展开▼